39.86
前日終値:
$40.20
開ける:
$40.2
24時間の取引高:
1.64M
Relative Volume:
0.69
時価総額:
$4.54B
収益:
$264.79M
当期純損益:
$-14.36M
株価収益率:
-362.36
EPS:
-0.11
ネットキャッシュフロー:
$-28.11M
1週間 パフォーマンス:
-7.28%
1か月 パフォーマンス:
+39.71%
6か月 パフォーマンス:
+67.27%
1年 パフォーマンス:
+162.06%
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
TGTX
Tg Therapeutics Inc
|
39.86 | 4.54B | 264.79M | -14.36M | -28.11M | -0.11 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-10-29 | 開始されました | TD Cowen | Buy |
2023-08-02 | アップグレード | Goldman | Sell → Neutral |
2023-06-26 | 再開されました | Jefferies | Buy |
2022-05-20 | 開始されました | BofA Securities | Underperform |
2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
2021-04-20 | 開始されました | Goldman | Neutral |
2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
2020-09-01 | 開始されました | JP Morgan | Overweight |
2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
2020-06-05 | 開始されました | Evercore ISI | Outperform |
2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
2019-11-27 | 再開されました | B. Riley FBR | Buy |
2019-02-06 | 再開されました | Jefferies | Buy |
2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
2017-11-14 | 再開されました | H.C. Wainwright | Buy |
2017-04-25 | 開始されました | Jefferies | Buy |
2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
2016-10-06 | 再開されました | Brean Capital | Buy |
2016-05-27 | 開始されました | SunTrust | Buy |
2015-12-01 | 開始されました | FBR Capital | Outperform |
2015-09-09 | 開始されました | Raymond James | Strong Buy |
2015-08-12 | 再開されました | H.C. Wainwright | Buy |
2015-06-19 | 繰り返されました | Brean Capital | Buy |
2014-12-11 | 繰り返されました | ROTH Capital | Buy |
2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? - MSN
Based On Its ROE, Is TG Therapeutics, Inc. (NASDAQ:TGTX) A High Quality Stock? - Simply Wall St
(TGTX) Investment Analysis and Advice - Stock Traders Daily
TG Therapeutics stock soars to 52-week high of $43.03 By Investing.com - Investing.com South Africa
TG Therapeutics stock soars to 52-week high of $43.03 - Investing.com India
TG Therapeutics (TGTX) technical analysisTG Therapeutics (NASDAQ:TGTX) - Benzinga
TG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to Analysts - Yahoo Finance
Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Epidemiology, Prevalence, Therapies and Companies by DelveInsight - The Globe and Mail
Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha
TG Therapeutics stock soars to 52-week high of $40.32 By Investing.com - Investing.com Australia
TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics stock soars to 52-week high of $40.32 - Investing.com India
TG Therapeutics Stock (TGTX): Advancing MS Treatment - Value the Markets
Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025? - Insider Monkey
(TGTX) Technical Data - Stock Traders Daily
TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter (NASDAQ:TGTX) - Seeking Alpha
10 Best Performing Growth Stocks in 2025 - Insider Monkey
Proficio Capital Partners LLC Buys Shares of 10,174 TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics call volume above normal and directionally bullish - TipRanks
Smartleaf Asset Management LLC Has $60,000 Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround - Yahoo Finance
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio? - Benzinga
Bank of New York Mellon Corp Increases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
Q2 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World
Why TG Therapeutics Stock Was Soaring This Week - MSN
TGTX Surges on Strong Q4 Results and Briumvi Success - GuruFocus.com
Why TG Therapeutics Shares Are Soaring Now - TipRanks
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week - MSN
TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - Yahoo Finance
Q1 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World
This Biotech Stock Hits Buy Point After Earnings Burst - MSN
HC Wainwright Reaffirms “Buy” Rating for TG Therapeutics (NASDAQ:TGTX) - Defense World
TG Therapeutics FY2025 EPS Estimate Boosted by HC Wainwright - Defense World
Why TG Therapeutics, Inc. (TGTX) Surged On Monday? - MSN
TG Therapeutics, Inc. (NASDAQ:TGTX) Holdings Decreased by Private Advisor Group LLC - Defense World
TG Therapeutics (NASDAQ:TGTX) Upgraded by StockNews.com to Hold Rating - Defense World
TG Therapeutics (NASDAQ:TGTX) Shares Up 5.2% After Earnings Beat - Defense World
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2024 Earnings Call Transcript - MSN
TG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX) - Defense World
TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide - MSN
TG Therapeutics stock soars to 52-week high of $36.89 By Investing.com - Investing.com South Africa
TG Therapeutics stock soars to 52-week high of $36.89 - Investing.com India
Cautious Outlook on TG Therapeutics Amid Competitive Pressures and Overvaluation Concerns - TipRanks
B. Riley Raises Price Target on TG Therapeutics to $53 From $38, Keeps Buy Rating -March 04, 2025 at 08:05 am EST - Marketscreener.com
H.C. Wainwright maintains TG Therapeutics stock Buy rating, $55 target - Investing.com India
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
Tg Therapeutics Inc (TGTX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Power Sean A | CFO |
Jan 06 '25 |
Sale |
28.53 |
10,021 |
285,939 |
660,611 |
大文字化:
|
ボリューム (24 時間):